title: Measles in Poland in 2011.
abstract: BACKGROUND
  Since 2001, Poland has been participating in Measles Elimination Program coordinated by the World Health Organization (WHO). Commitment in the implementation of this program is to maintain 95% of the population vaccinated, recording all suspected cases of measles and confirmation of diagnosis in the Reference Laboratory.
  
  
  OBJECTIVE
  To evaluate the epidemiology of measles in Poland in 2011, and the degree of implementation of the Measles Elimination Program.
  
  
  METHODS
  The epidemiological situation of measles in 2011 was assessed on the basis of the individual reported cases/suspected cases of measles, sent to the NIPH-NIH by regional sanitary-epidemiological stations collected and presented in the newsletter" Infectious Diseases and Poisonings in Poland in 2011" and "Vaccinations in Poland in 2011" (MP Czarkowski et al, Warsaw 2012, NIZP-PZH, GIS).
  
  
  RESULTS
  In 2011, 38 reported cases of measles (incidence 0.10/100,000), of which 29 (76.3%) were laboratory-confirmed. There have been four outbreaks of measles, total of 12 people. The highest incidence was observed in patients 25-29 years old (0.28/100,000), then in 30-34 (0.26/100,000). 23 people were hospitalized (60.5%). No death from measles was reported. Vaccination status of children and youth aged 2 to 11 years ranged from 84.4% to 99.7% (primary vaccination in children born in 2010 - 2005) and from 53.7% to 60.3% (booster, in born 2004 - 2000).
  
  
  CONCLUSIONS
  The epidemiological situation of measles in 2011, worsen in relation to the previous year. A persistent low number of suspected cases of measles indicates low sensitivity of the surveillance system.
authors.affiliation: Department of Epidemiology, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland. ekarasek@pzh.gov.pl
authors.forename: Ewa
authors.initials: E
authors.lastname: Karasek
authors.forename: Iwona
authors.initials: I
authors.lastname: Paradowska-Stankiewicz
mesh_terms: D017677:Age Distribution; D002648:Child; D002669:Child Welfare / Q000706:statistics & numerical data*; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control / Q000706:statistics & numerical data*; D005260:Female; D006304:Health Status; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008457:Measles / Q000453:epidemiology* / Q000517:prevention & control; D008458:Measles Vaccine / Q000627:therapeutic use; D011044:Poland / Q000453:epidemiology; D012042:Registries / Q000706:statistics & numerical data*; D012307:Risk Factors; D012698:Serologic Tests / Q000706:statistics & numerical data
chemical_list: D008458:Measles Vaccine